Google's Willow Quantum Chip Achieves 13,000x Speedup Over Supercomputers in Major Breakthrough
TripleG News
Mar 12, 2026
Google has unveiled a groundbreaking achievement with its Willow quantum chip, which ran the Quantum Echoes algorithm—designed to model atomic interactions via nuclear magnetic resonance—13,000 times faster than classical supercomputers. Featuring 105 qubits with exceptional fidelities of 99.97% for single-qubit gates and 99.88% for entangling gates, Willow also excels in error correction, reducing errors exponentially as qubit counts scale from 3x3 to 7x7 grids. This 'below threshold' performance marks the first scalable quantum error correction on a superconducting system, verifying results that can be cross-checked by other quantum hardware.
The significance of Willow lies in its shift from theoretical benchmarks to practical, verifiable computations, proving quantum systems can outperform classical ones in precision and complexity tasks. Unlike prior demos like Random Circuit Sampling, Quantum Echoes simulates real physical experiments, paving the way for applications in drug discovery, materials science for magnets, and even black hole modeling. This verifiable quantum advantage signals the transition from research prototypes to engineering scalable quantum computers, impacting fields like medicine, energy, and AI by solving problems intractable for today's supercomputers.
Market reactions were swift, with shares of pure-play quantum firms like IonQ, Rigetti, and D-Wave dropping double-digits, while superconducting leaders IBM and Google held strong, hinting at a potential consolidation around dominant qubit technologies. Looking ahead, Google targets long-lived logical qubits and useful beyond-classical computations on Willow-scale hardware. With IBM eyeing 200 logical qubits by 2029, the quantum race is accelerating toward data-center-ready systems within years.
Stay Ahead of the Curve
Join 10,000+ tech enthusiasts
Weekly digest · Curated picks · No spam
Related Articles
AI Breakthrough: New Framework Predicts Cancer Treatment Success, Boosts Survival by 15%
AstraZeneca and Tempus AI have unveiled a predictive biomarker modeling framework leveraging contrastive learning, LLMs, and machine learning to forecast treatment responses in immuno-oncology trials. The innovation delivers a 15% survival advantage over traditional methods, paving the way for precision cancer care.
Quantum Breakthrough: Scientists Crack the Code to Read Elusive Majorana Qubits
Researchers have pioneered a quantum capacitance technique to read the hidden states of Majorana qubits, verifying their noise resistance and millisecond coherence times. This milestone paves the way for stable, fault-tolerant quantum computers.
Breakthrough Prostate Cancer Immunotherapy VIR-5500 Delivers Stunning Early Trial Results
Early trials of VIR-5500, a novel T-cell engager, showed dramatic PSA reductions in advanced prostate cancer patients with minimal side effects. Experts hail the findings as a potential game-changer for a disease long resistant to immunotherapy.